Afuco™ Anti-C. diff Toxin A ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-716) (CAT#: AFC-TAB-716)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to toxin A [C. difficile]. It is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficileinfection.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Human
- Type
- ADCC enhanced antibody
- Species Reactivity
- C. difficile
- Applications
- IP, IF, FuncS, FC, Neut, ELISA
- Conjugate
- Unconjugated
- Generic Name
- Actoxumab
- Related Disease
- Clostridium difficileinfectious diarrhea
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- CDA-1; MBL-CDA1; tcdA; toxA
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Actoxumab"
DrugMonitor™ Anti-Actoxumab Antibody (VS-1224-YC19)Actoxumab is a human monoclonal antibody aimed at preventing the recurrence of Clostridioides difficile infections. The DrugMonitor™ Anti-Actoxumab Antibody (VS-1224-YC19) is an anti-drug antibody (ADA) against Actoxumab. This drug-based antibody is raised in mice immunized with the Actoxumab. The anti-Actoxumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Actoxumab in samples.
See other products for "C. difficile Toxin A"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-146CT | Mouse Anti-C. difficile toxin A Recombinant Antibody (MRO-146CT) | WB, ELISA, Neut | Mouse IgG |
MRO-147CT | Mouse Anti-C. difficile toxin A Recombinant Antibody (MRO-147CT) | WB, ELISA, Neut | Mouse IgG |
MRO-148CT | Mouse Anti-C. difficile toxin A Recombinant Antibody (MRO-148CT) | WB, ELISA, Neut | Mouse IgG |
MRO-146CT-S(P) | Mouse Anti-C. difficile toxin A Recombinant Antibody; scFv Fragment (MRO-146CT-S(P)) | WB, ELISA, Neut | Mouse scFv |
MOB-0355MC | Recombinant Mouse Anti-Clostridium difficile Toxin A antibody | ELISA |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-716. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: FC, IHC, FuncS, Inhib, Cyt
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: ELISA, FC, WB, FuncS
Application: WB, IHC, ELISA, FC
Application: ELISA, FC, IF, WB
Application: FC, IHC-Fr, IP, ELISA, Block
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: Neut, IHC, Activ, FuncS, IF, ELISA
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.